96 results
DEF 14A
CHRO
Chromocell Therapeutics Corp
26 Sep 24
Definitive proxy
5:08pm
the right to acquire within sixty (60) days of September 26, 2024 is deemed to be outstanding, but is not deemed to be outstanding for the purpose … for issuance thereunder by 1,500,000 shares, which will not take effect without stockholder approval.
The purpose of the 2023 Plan is to encourage
PRE 14A
CHRO
Chromocell Therapeutics Corp
9 Sep 24
Preliminary proxy
5:30pm
to be outstanding for the purpose of computing the percentage ownership of any other person. The inclusion herein of any shares of Common Stock or other … shares, which will not take effect without stockholder approval.
The purpose of the 2023 Plan is to encourage key employees, directors
424B3
CHRO
Chromocell Therapeutics Corp
6 Aug 24
Prospectus supplement
4:49pm
jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession … purpose, our management will have broad discretion as to the application of such net proceeds and could use them for purposes other than those
424B3
qm86ry2n40k
29 Jul 24
Prospectus supplement
9:08am
424B3
fofocr fy
29 Jul 24
Prospectus supplement
9:07am
8-K
EX-10.1
n34y3vq4bht 1btu
29 Jul 24
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.3
lhjjiiq
29 Jul 24
Entry into a Material Definitive Agreement
9:06am
8-K
EX-4.1
04g xaa2l4
29 Jul 24
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.2
orq1k cgql22bgq
29 Jul 24
Entry into a Material Definitive Agreement
9:06am
10-Q
EX-10.2
l30gf70pq a4b
15 May 24
Quarterly report
4:06pm
10-Q
EX-10.3
3o8zc4atwv6j
15 May 24
Quarterly report
4:06pm
424B3
ght8a
16 Apr 24
Prospectus supplement
5:49pm
424B3
c7km6
16 Apr 24
Prospectus supplement
5:45pm
10-K
EX-97.1
ggqqe1s
16 Apr 24
Annual report
4:48pm
10-K
elleb69a zixxm
16 Apr 24
Annual report
4:48pm
10-K
EX-19.1
yofe 23b22cl2lmdu21
16 Apr 24
Annual report
4:48pm
S-8
EX-107
0m0o2o1
12 Apr 24
Registration of securities for employees
7:22pm